CENTRAL VALLEY ADVISORS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2010698 SACRAMENTO, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$223,494

-$22,354 QoQ

Shares Held

1,769

+0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#1,857

of 2,266 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 99% Shared 1% None 0%

Healthcare · as of Jun 30, 2026

CENTRAL VALLEY ADVISORS, LLC holds $2,448,412 across 5 Drug Manufacturers - General names. GILD ranks #5 (9.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,091	$1,038,990
2	ABBV	AbbVie Inc.	1,883	$473,837
3	LLY	ELI LILLY & Co	310	$371,823
4	MRK	Merck & Co., Inc.	2,648	$340,268
5	GILD	Gilead Sciences, Inc. This page	1,769	$223,494

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$223,494	1,769	+0.3%	Shares	Sole	2026-07-22
2026-03-31	$245,848	1,764	—	Shares	Sole	2026-04-09
No filing history on record for this holder in this stock.